Rongwei Zhao, Meng Xu, Xiaoyang Yu, Anne R. Wondisford, Rachel M. Lackner, Jayme Salsman, Graham Dellaire, David M. Chenoweth, Roderick J. O'Sullivan, Xiaolan Zhao, Huaiying Zhang
{"title":"SUMO promotes DNA repair protein collaboration to support alternative telomere lengthening in the absence of PML","authors":"Rongwei Zhao, Meng Xu, Xiaoyang Yu, Anne R. Wondisford, Rachel M. Lackner, Jayme Salsman, Graham Dellaire, David M. Chenoweth, Roderick J. O'Sullivan, Xiaolan Zhao, Huaiying Zhang","doi":"10.1101/gad.351667.124","DOIUrl":null,"url":null,"abstract":"The alternative lengthening of telomeres (ALT) pathway maintains telomere length in a significant fraction of cancers that are associated with poor clinical outcomes. A better understanding of ALT mechanisms is therefore necessary for developing new treatment strategies for ALT cancers. SUMO modification of telomere proteins contributes to the formation of ALT telomere-associated PML bodies (APBs), in which telomeres are clustered and DNA repair proteins are enriched to promote homology-directed telomere DNA synthesis in ALT. However, it is still unknown whether—and if so, how—SUMO supports ALT beyond APB formation. Here, we show that SUMO condensates that contain DNA repair proteins enable telomere maintenance in the absence of APBs. In PML knockout ALT cell lines that lack APBs, we found that SUMOylation is required for manifesting ALT features independent of PML and APBs. Chemically induced telomere targeting of SUMO produces condensate formation and ALT features in PML-null cells. This effect requires both SUMOylation and interactions between SUMO and SUMO interaction motifs (SIMs). Mechanistically, SUMO-induced effects are associated with the accumulation of DNA repair proteins, including Rad52, Rad51AP1, RPA, and BLM, at telomeres. Furthermore, Rad52 can undergo phase separation, enrich SUMO at telomeres, and promote telomere DNA synthesis in collaboration with the BLM helicase in a SUMO-dependent manner. Collectively, our findings suggest that SUMO condensate formation promotes collaboration among DNA repair factors to support ALT telomere maintenance without PML. Given the promising effects of SUMOylation inhibitors in cancer treatment, our findings suggest their potential use in perturbing telomere maintenance in ALT cancer cells.","PeriodicalId":12591,"journal":{"name":"Genes & development","volume":"35 1","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genes & development","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1101/gad.351667.124","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The alternative lengthening of telomeres (ALT) pathway maintains telomere length in a significant fraction of cancers that are associated with poor clinical outcomes. A better understanding of ALT mechanisms is therefore necessary for developing new treatment strategies for ALT cancers. SUMO modification of telomere proteins contributes to the formation of ALT telomere-associated PML bodies (APBs), in which telomeres are clustered and DNA repair proteins are enriched to promote homology-directed telomere DNA synthesis in ALT. However, it is still unknown whether—and if so, how—SUMO supports ALT beyond APB formation. Here, we show that SUMO condensates that contain DNA repair proteins enable telomere maintenance in the absence of APBs. In PML knockout ALT cell lines that lack APBs, we found that SUMOylation is required for manifesting ALT features independent of PML and APBs. Chemically induced telomere targeting of SUMO produces condensate formation and ALT features in PML-null cells. This effect requires both SUMOylation and interactions between SUMO and SUMO interaction motifs (SIMs). Mechanistically, SUMO-induced effects are associated with the accumulation of DNA repair proteins, including Rad52, Rad51AP1, RPA, and BLM, at telomeres. Furthermore, Rad52 can undergo phase separation, enrich SUMO at telomeres, and promote telomere DNA synthesis in collaboration with the BLM helicase in a SUMO-dependent manner. Collectively, our findings suggest that SUMO condensate formation promotes collaboration among DNA repair factors to support ALT telomere maintenance without PML. Given the promising effects of SUMOylation inhibitors in cancer treatment, our findings suggest their potential use in perturbing telomere maintenance in ALT cancer cells.
端粒替代性延长(ALT)途径可维持相当一部分癌症的端粒长度,而这些癌症的临床预后较差。因此,有必要更好地了解 ALT 机制,以便为 ALT 癌症制定新的治疗策略。端粒蛋白的SUMO修饰有助于ALT端粒相关PML体(APB)的形成,在APB中端粒聚集,DNA修复蛋白富集,从而促进ALT中同源定向端粒DNA合成。然而,除了APB的形成外,SUMO是否--如果是--如何支持ALT仍是未知数。在这里,我们发现含有DNA修复蛋白的SUMO凝聚物能在没有APB的情况下维持端粒。在缺乏 APB 的 PML 基因敲除 ALT 细胞系中,我们发现 SUMOylation 是独立于 PML 和 APB 的 ALT 特征表现所必需的。化学诱导的端粒靶向 SUMO 在 PML 基因缺失细胞中产生凝集物形成和 ALT 特征。这种效应需要SUMO酰化以及SUMO和SUMO相互作用基序(SIMs)之间的相互作用。从机理上讲,SUMO 诱导的效应与 DNA 修复蛋白(包括 Rad52、Rad51AP1、RPA 和 BLM)在端粒的积累有关。此外,Rad52可以发生相分离,在端粒处富集SUMO,并以SUMO依赖的方式与BLM螺旋酶合作促进端粒DNA合成。总之,我们的研究结果表明,SUMO凝聚物的形成促进了DNA修复因子之间的协作,从而在没有PML的情况下支持ALT端粒的维持。鉴于 SUMOylation 抑制剂在癌症治疗中的良好效果,我们的研究结果表明它们有可能用于干扰 ALT 癌细胞的端粒维持。
期刊介绍:
Genes & Development is a research journal published in association with The Genetics Society. It publishes high-quality research papers in the areas of molecular biology, molecular genetics, and related fields. The journal features various research formats including Research papers, short Research Communications, and Resource/Methodology papers.
Genes & Development has gained recognition and is considered as one of the Top Five Research Journals in the field of Molecular Biology and Genetics. It has an impressive Impact Factor of 12.89. The journal is ranked #2 among Developmental Biology research journals, #5 in Genetics and Heredity, and is among the Top 20 in Cell Biology (according to ISI Journal Citation Reports®, 2021).